ORIC | Oric PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$9.59
+$0.52 (+5.73%)

Oric Pharmaceuticals (ORIC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Aug 2026, but the two have been closing on each other and a death cross is projected within 20 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Weekly as of 30 Oct 16:00 ET

Price
between the two $9.24 vs 50 $10.88 / 200 $9.17
Projection
Death cross estimated 15+ weeks out
Test
No active test
Last cross
Golden cross week of 30 Dec 2024 ยท projected 5 bars out ยท tested 6 bars

4-hour as of 3 Nov 16:00 ET

Price
below both $9.59 vs 50 $11.62 / 200 $11.83
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 2 Nov 2026 ยท projected 14 bars out

Cross history

26
crosses on record since 2021
13 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
2 Nov 2026Death4-hour14 bars outActive Cross Test
14 Aug 2026Golden steepdaily24 bars outNot tested
21 Jul 2026Golden4-hour28 bars outNot tested
8 May 2026Death moderatedaily21 bars outNot tested
20 Apr 2026Death4-hour22 bars out6 bar cross test

About ORIC

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$15.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.